Amends definitions of diagnostic, topical therapeutic, and therapeutic pharmaceutical agents for glaucoma and ocular hypertension in optometry.

This bill amends the definitions of diagnostic pharmaceuticals, topical therapeutic pharmaceutical agents, and therapeutic pharmaceutical agents for the treatment of glaucoma and ocular hypertension in the practice of optometry. It specifies that optometrists certified for topical therapeutic agents can use and prescribe all FDA-approved topical therapeutic agents. It also defines therapeutic pharmaceutical agents for glaucoma and ocular hypertension, allowing certified optometrists to use and prescribe these agents. The changes take effect immediately.

Amends definitions of diagnostic, topical therapeutic, and therapeutic pharmaceutical agents for glaucoma and ocular hypertension in optometry.

This bill amends the definitions of diagnostic pharmaceuticals, topical therapeutic pharmaceutical agents, and therapeutic pharmaceutical agents for the treatment of glaucoma and ocular hypertension in the practice of optometry. It specifies that optometrists certified for topical therapeutic agents can use and prescribe all FDA-approved topical therapeutic agents. It also defines therapeutic pharmaceutical agents for glaucoma and ocular hypertension, allowing certified optometrists to use and prescribe these agents. The changes take effect immediately.